When.com Web Search

  1. Ads

    related to: enlarged prostate and cancer risk ratio meaning

Search results

  1. Results From The WOW.Com Content Network
  2. Prostate enlargement, how it affects men as they age, and its ...

    www.aol.com/prostate-enlargement-affects-men-age...

    Screening for prostate cancer may include a digital rectal exam, where the clinician assesses for an enlarged prostate, and/or a blood test to measure a prostate-specific antigen (PSA) level.

  3. What's the difference between an enlarged prostate and ... - AOL

    www.aol.com/lifestyle/whats-difference-between...

    Although some symptoms can overlap, it's important to note that an enlarged prostate is not a sign of cancer and doesn't raise the risk of getting prostate cancer, according to the National Cancer ...

  4. Benign prostatic hyperplasia - Wikipedia

    en.wikipedia.org/wiki/Benign_prostatic_hyperplasia

    Although prostate specific antigen levels may be elevated in males with BPH, the condition does not increase the risk of prostate cancer. [8] The prevalence of enlarged prostate, and symptoms of an enlarged prostate, in men of different ages. [9] [10] Graphic from NHS England. [11]

  5. What you should know to reduce the risk of prostate cancer - AOL

    www.aol.com/prostate-cancer-urologist-explains...

    Prostate MRI technology offers a detailed, high-definition view of the prostate gland. It enables us to identify suspicious lesions within the prostate gland that could harbor prostate cancer.

  6. Prostate cancer - Wikipedia

    en.wikipedia.org/wiki/Prostate_cancer

    Prostate cancer is the most diagnosed cancer in men in over half of the world's countries, and the leading cause of cancer death in men in around a quarter of countries. [91] Prostate cancer is rare in those under 40 years old, [92] and most cases occur in those over 60 years, [2] with the average person diagnosed at 67. [93]

  7. Management of prostate cancer - Wikipedia

    en.wikipedia.org/wiki/Management_of_prostate_cancer

    The risk of disease progression and metastasis (spread of the cancer) may be increased, but this increase risk appears to be small if the program of surveillance is followed closely, generally including serial PSA assessments and repeat prostate biopsies every 1–2 years depending on the PSA trends.